Helen Slaski – BioLeader Interview
Helen Slaski BioLeader Interview - Helen Slaski, Chief Executive Officer Cambridge Science Centre (October 2021) Qualifying as a Pharmacist from London School of Pharmacy (now UCL) and specialising in Pharmaceutical Engineering Sciences, I started my working career with GSK in operations management, moving to international production support and subsequently as Executive Assistant to the Group Technical Director. Escaping to complete an MBA at London Business School, I have since had forays into strategic consultancy, newspaper and magazine publishing, FMCG manufacturing, medical device design and development and an organisation of international language schools. I was thrilled to join Cambridge Science [...]
Fiona Nielsen – BioLeader Interview
Fiona Nielsen BioLeader Interview - Fiona Nielsen, Chief Operating Officer at o2h Technology (October 2021) Fiona Nielsen is the Chief Operating Officer at o2h Technology, the software services arm of o2h Group. The o2h Technology team of expert engineers are specialised in building web and mobile app MVPs for start-ups primarily in life sciences, health tech and green tech. Fiona got her degrees in computer science and bioinformatics in Denmark and the Netherlands. She moved to Cambridge to specialise in genomics and next-generation sequencing, working for Illumina. She left Illumina to found the charity DNAdigest and the company Repositive [...]
Alex Leech – BioLeader Interview
Alex Leech BioLeader Interview - Alex Leech, Chair at 2N Pharma, Company Builder and CEO (September 2021) An experienced company creator and CEO with a successful track record. Key milestones in your career journey to date? As CEO, raising $82m in 2020 for Alchemab, which we built in 16 months from a standing start; as a result of having a world-class team and a great concept. This and our timing created a great UK company and strong investment opportunity. Leading Creabilis between 2015-2017, as CEO; with the remit to exit; during which we explored listing and ultimately sold the [...]
Barbara Domayne-Hayman – BioLeader Interview
Barbara Domayne-Hayman BioLeader Interview - Barbara Domayne-Hayman, Entrepreneur-in-Residence at The Francis Crick Institute and Board Director (August 2021) I am a company builder and deal-maker in biotech, who has successfully transitioned from working in large organisations to an entrepreneurial environment and mindset. I want to make a real contribution to society through the commercialisation of new science. I also have a passion for opera and playing the harp and piano. Key milestones in your career journey to date? I received amazing support from my parents to pursue whatever career route I chose - which was initially a difficult decision [...]
Dr. David Atkins – BioLeader Interview
Dr. David Atkins BioLeader Interview - Dr. David Atkins, CEO Congenica (August 2021) Accomplished global healthcare leader with strong emerging markets experience in a broad range of medical device sectors and specialty clinical services. Expertise includes clinical and molecular diagnostics, anatomic pathology, wound management, minimally invasive and general surgery, orthopaedics, sterilisation, aesthetics and cellular diagnostics. Business leadership Internationally in US, Canada, EU, Emerging Markets (Middle East, Africa, Asia, Latin America). Start-up ventures, turnaround and high-growth enterprise expertise. Broad functional expertise in sales and marketing, R&D pipeline, product development, QRC and operations and business development. Key milestones in your career [...]
Dr. Kevin Pojasek – BioLeader Interview
Dr. Kevin Pojasek BioLeader Interview - Dr. Kevin Pojasek, CEO Enara Bio (July 2021) Dr. Pojasek is a biotech executive with nearly 20 years’ experience founding and leading companies in the US and UK. Dr. Pojasek is currently President and CEO of Enara Bio, as well as Founder and Director of Catamaran Bio and Venture Partner for SV Health Investors. Prior to joining SV, Dr. Pojasek was Chief Strategy and Business Officer and a member of the executive leadership team at Immunocore Ltd. Prior to joining Immunocore, Dr. Pojasek was President, Chief Executive Officer of Quartet Medicine, a company [...]
Bobby Anderson – BioInvestors Second Edition (Part 5)
For the second edition of BioInvestors (Part 5) we are pleased to be joined by key expert investor Bobby Anderson, Vice President, Silicon Valley Bank.
Deborah Harland – BioInvestors Second Edition (Part 4)
For the second edition of BioInvestors (Part 4) we are pleased to be joined by key expert investor Deborah Harland, Venture Partner, SR One Capital Management.
BioInvestors Second Edition (Part 3)
For the second edition of BioInvestors (Part 3) we are pleased to be joined by key expert investors: Edward Hodgkin, Partner, Syncona, Dina Chaya, Partner, NeoMed, and Roel Bulthuis, Managing Partner, INKEF Capital
What Are The Hot Investment Areas? – Panel Discussion (Anglonordic Life Science Conference)
Last month, Amber Tong, Senior Editor at Endpoints, chaired a panel of Europe's leading VC investors during the Anglonordic life science conference where they were asked 'What Are The Hot Investment Areas?' Amber was joined by a fantastic panel consisting of Hakan Goker, Deborah Harland, Nanna Lüneborg, and Stephan Christgau. The discussion was extremely captivating, the investors spoke about a range of things including how the pandemic has impacted their business, the essential components to building a successful biotech, and the current hot markets for investment. Watch the panel discussion again here.